Based on 1 analyst offering 12 month price targets for Cardiol Therapeutics Inc
Min Forecast
$9.00+757.14%
Avg Forecast
$9.00+757.14%
Max Forecast
$9.00+757.14%
Should I buy or sell CRDL stock?
Based on 1 analyst offering ratings for Cardiol Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CRDL's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CRDL as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More
Be the first to know when Wall Street analysts revise their CRDL stock forecasts and price targets.
Is Cardiol Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: CRDL) stock is to Buy CRDL stock.
Out of 1 analyst, 0 (0%) are recommending CRDL as a Strong Buy, 1 (100%) are recommending CRDL as a Buy, 0 (0%) are recommending CRDL as a Hold, 0 (0%) are recommending CRDL as a Sell, and 0 (0%) are recommending CRDL as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year CRDL price target, the average CRDL price target is $9.00, with the highest CRDL stock price forecast at $9.00 and the lowest CRDL stock price forecast at $9.00.
The Wall Street analyst predicted that Cardiol Therapeutics's share price could reach $9.00 by Feb 10, 2027. The average Cardiol Therapeutics stock price prediction forecasts a potential upside of 757.14% from the current CRDL share price of $1.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.